About Probity Medical Research Inc.

Since 1995, Probity Medical Research (PMR) has been providing support for clinical research sites from our head office in Waterloo, Ontario, Canada. During this time, PMR has grown and now has research facilities in Australia, Canada, Chile, Mexico, and the United States.

PMR is a clinical research company that trains and provides administrative support for clinical trial sites. Although PMR's first research site was a Dermatology site, its research sites now include Urology, Gynaecology, Rheumatology, Vaccines, Women's Health, Cardiology, and Oncology.

Dr. Kim Papp, Dermatologist Specialist in PsoriasisPMR's President is internationally recognized dermatology researcher Dr. Kim Papp. For 21 years, Dr. Papp's facility has been conducting research in dermatology for conditions including psoriasis, psoriatic arthritis, eczema, acne, toenail fungus, skin cancer, and many other dermatological conditions as well as vaccines, antibiotics, and hypertension. Over 4,000 patients in Southwestern Ontario have participated in studies Dr. Papp has run.


The physicians that work with the PMR consortium have conducted over 500 clinical research studies involving more than 15,000 patients.

This experience has allowed our physicians to publish 300 research papers on their work in journals such as:

  • New England Journal of Medicine
  • American Journal of Cardiology
  • American Journal of Hematology
  • Annals of Internal Medicine
  • Arthritis & Rheumumatism
  • Australasian Journal of Dermatology
  • British Journal of Dermatology
  • British Journal of Urology International
  • Canadian Journal of Gastroenterology
  • Clinical Infectious Diseases
  • Clinical Lymphoma
  • Cutis
  • European Urology


  • Lancet
  • Gastroenterology
  • Gastrointestinal Endoscopy
  • Human Molecular Genetics
  • International Journal of Radiation Oncology Biology Physics
  • Journal of Cutaneous Medicine and Surgery
  • Journal of Allergy and Clinical Immunology
  • Journal of American Medical Association
  • Journal of the American Academy of Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of Urology
  • Journal Rheumatology
  • Medical Journal of Australia
  • Modern Medicine
  • Ophthalmology
  • Pediatrics
  • Urology


Contact us for more information about Probity Medical Research.


RSS Feed PMR Sponsors News
Next » Showing 1-3 of 10 entries.

Probity Medical Research Pays Tribute to Urological Research During Bladder Health Week

Bladder Health Week is a welcome reminder of the efforts urology researchers make to expand and improve patients’ treatment options for bladder diseases. 

Bladder cancer is but one of many diseases that affect the urinary system.  Conditions like interstitial cystitis (IC) and bladder pain syndrome (BPS) are painful illnesses that can seriously impact one’s health and happiness.  Overactive bladder, nocturia, and urinary incontinence can disrupt sleep, make everyday tasks difficult, and have a devastating impact on one’s social life.  In many cases, bladder conditions can lead to problems in professional and personal relationships.

Posted November 15, 2013 0 comments 0 recommendations

On World Psoriasis Day, PMR Renews Commitment to Help Develop New Psoriasis Treatments

October 29 is World Psoriasis Day, a time to raise awareness of a chronic condition affecting millions worldwide.  The facts are striking – nearly 3 percent of the world’s population has psoriasis.

Posted October 29, 2013 0 comments 0 recommendations

New Technology is Game-Changer for Suprapubic Catheterization

BIGFORK, Montana and KITCHENER Ontario, Canada, Swan Valley Medical, Incorporated, together with St. Mary’s General Hospital announced that the T-SPeC® Surgical System was used in its first live human clinical cases on August 15, 2012, for the treatment of chronic urinary retention and to evaluate patient comfort and improved safety.

Posted September 12, 2012 0 comments 0 recommendations
Next »

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.